A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells
NMR-based metabolomics is a very effective tool to assess the tumor response to drugs by providing insights for their mode of action. Recently, a novel Pt(II) complex, [Pt(ƞ1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-phenanthroline), Pt-EtOMeSOphen, was synthesized and studied for its antitumor activity...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Bioinorganic Chemistry and Applications |
Online Access: | http://dx.doi.org/10.1155/2022/8932137 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832565493987278848 |
---|---|
author | Federica De Castro Erika Stefàno Erik De Luca Antonella Muscella Santo Marsigliante Michele Benedetti Francesco Paolo Fanizzi |
author_facet | Federica De Castro Erika Stefàno Erik De Luca Antonella Muscella Santo Marsigliante Michele Benedetti Francesco Paolo Fanizzi |
author_sort | Federica De Castro |
collection | DOAJ |
description | NMR-based metabolomics is a very effective tool to assess the tumor response to drugs by providing insights for their mode of action. Recently, a novel Pt(II) complex, [Pt(ƞ1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-phenanthroline), Pt-EtOMeSOphen, was synthesized and studied for its antitumor activity against eight human cancer cell lines. Pt-EtOMeSOphen showed higher cytotoxic effects than cisplatin in most of the cancer cell lines and in particular against the neuroblastoma cell line (SH-SY5Y). In this study, the mechanism of action of Pt-EtOMeSOphen on SH-SY5Y cells was investigated using 1H NMR-based metabolomics and compared with cisplatin. The observed time response of SH-SY5Y cells under treatment revealed a faster action of Pt-EtOMeSOphen compared with cisplatin, with a response already observed after six hours of exposure, suggesting a cytosolic target. NMR-based metabolomics demonstrated a peculiar alteration of the glutathione metabolism pathway and the diacylglycerol expression. |
format | Article |
id | doaj-art-20b281fd673e49f39730019a234fa4d7 |
institution | Kabale University |
issn | 1687-479X |
language | English |
publishDate | 2022-01-01 |
publisher | Wiley |
record_format | Article |
series | Bioinorganic Chemistry and Applications |
spelling | doaj-art-20b281fd673e49f39730019a234fa4d72025-02-03T01:07:22ZengWileyBioinorganic Chemistry and Applications1687-479X2022-01-01202210.1155/2022/8932137A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer CellsFederica De Castro0Erika Stefàno1Erik De Luca2Antonella Muscella3Santo Marsigliante4Michele Benedetti5Francesco Paolo Fanizzi6Department of Biological and Environmental Sciences and Technologies (DiSTeBA)Department of Biological and Environmental Sciences and Technologies (DiSTeBA)Department of Biological and Environmental Sciences and Technologies (DiSTeBA)Department of Biological and Environmental Sciences and Technologies (DiSTeBA)Department of Biological and Environmental Sciences and Technologies (DiSTeBA)Department of Biological and Environmental Sciences and Technologies (DiSTeBA)Department of Biological and Environmental Sciences and Technologies (DiSTeBA)NMR-based metabolomics is a very effective tool to assess the tumor response to drugs by providing insights for their mode of action. Recently, a novel Pt(II) complex, [Pt(ƞ1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-phenanthroline), Pt-EtOMeSOphen, was synthesized and studied for its antitumor activity against eight human cancer cell lines. Pt-EtOMeSOphen showed higher cytotoxic effects than cisplatin in most of the cancer cell lines and in particular against the neuroblastoma cell line (SH-SY5Y). In this study, the mechanism of action of Pt-EtOMeSOphen on SH-SY5Y cells was investigated using 1H NMR-based metabolomics and compared with cisplatin. The observed time response of SH-SY5Y cells under treatment revealed a faster action of Pt-EtOMeSOphen compared with cisplatin, with a response already observed after six hours of exposure, suggesting a cytosolic target. NMR-based metabolomics demonstrated a peculiar alteration of the glutathione metabolism pathway and the diacylglycerol expression.http://dx.doi.org/10.1155/2022/8932137 |
spellingShingle | Federica De Castro Erika Stefàno Erik De Luca Antonella Muscella Santo Marsigliante Michele Benedetti Francesco Paolo Fanizzi A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells Bioinorganic Chemistry and Applications |
title | A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells |
title_full | A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells |
title_fullStr | A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells |
title_full_unstemmed | A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells |
title_short | A NMR-Based Metabolomic Approach to Investigate the Antitumor Effects of the Novel [Pt(η1-C2H4OMe)(DMSO)(phen)]+ (phen = 1,10-Phenanthroline) Compound on Neuroblastoma Cancer Cells |
title_sort | nmr based metabolomic approach to investigate the antitumor effects of the novel pt η1 c2h4ome dmso phen phen 1 10 phenanthroline compound on neuroblastoma cancer cells |
url | http://dx.doi.org/10.1155/2022/8932137 |
work_keys_str_mv | AT federicadecastro anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT erikastefano anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT erikdeluca anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT antonellamuscella anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT santomarsigliante anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT michelebenedetti anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT francescopaolofanizzi anmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT federicadecastro nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT erikastefano nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT erikdeluca nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT antonellamuscella nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT santomarsigliante nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT michelebenedetti nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells AT francescopaolofanizzi nmrbasedmetabolomicapproachtoinvestigatetheantitumoreffectsofthenovelptē1c2h4omedmsophenphen110phenanthrolinecompoundonneuroblastomacancercells |